Medicinal Cannabis Matters: Friday Roundup - 17 July 2026

New Research Explores Cannabinoids and Lung Cancer Cells

Researchers in Germany have published new study findings on how cannabinoids interact with lung cancer cells.

Reported by the International Cannabis Business Conference, the study found that certain cannabinoids were able to trigger cell death in lung cancer cells under laboratory conditions. Specific cannabinoids appeared to activate natural processes within cancer cells that led to their death, while also reducing the cells' ability to grow and multiply. Although these findings are promising, they were observed in cells grown in a laboratory rather than in patients, meaning further research and clinical trials are essential before any potential use can be established.

Studies like this are valuable because they help researchers better understand how cannabinoids work within the body and may inform future clinical research.

Long-Term Improvements Reported in Chronic Lower Back Pain

New research highlighted by Cannabis Health News has found that medicinal cannabis was associated with sustained improvements in people living with chronic lower back pain.

The study reported ongoing reductions in pain severity alongside improvements in quality of life for many patients receiving treatment. Chronic lower back pain is one of the most common reasons patients seek specialist care and can have a significant impact on mobility, sleep, work and mental wellbeing.

Importantly, the findings suggest that these benefits were maintained over time rather than being short-lived, adding to the evidence supporting medicinal cannabis as a potential treatment option for some patients living with chronic pain.

Could Cannabinoids Help Treat Dementia Symptoms?

Research has emerged exploring whether cannabinoids may have a role in managing symptoms associated with dementia and Alzheimer's disease.

The report discusses how researchers are investigating compounds such as CBD and THC for their potential to help address symptoms including agitation, sleep disturbances and anxiety, while also exploring whether cannabinoids may have neuroprotective properties.

Although this area of research is still in its early stages, interest continues to grow as scientists look for new ways to improve quality of life for people living with neurodegenerative conditions.

From chronic pain and neurological conditions to laboratory-based cancer research, scientists continue to explore where cannabinoids may have a role in future healthcare. Even though it's important to distinguish between early-stage research and established clinical evidence, each new study helps strengthen our understanding of how medicinal cannabis may support patients living with complex health conditions.

If you're considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just two minutes.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.